Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor?

被引:48
作者
Langendijk, JA
Tjwa, MKT
de Jong, JMA
ten Velde, GPM
Wouters, EFM
机构
[1] Radiotherapeut Inst Limburg, Heerlen, Netherlands
[2] De Wever Hosp, Dept Resp Dis, Heerlen, Netherlands
[3] Univ Hosp Maastricht, Dept Resp Dis, Maastricht, Netherlands
关键词
non-small cell lung carcinoma; radiotherapy; brachytherapy; massive haemoptysis;
D O I
10.1016/S0167-8140(98)00103-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: This retrospective study was conducted to investigate whether endobronchial brachytherapy (EBB) is a risk factor for massive haemoptysis in patients primarily treated by a combination of EBB and external irradiation (XRT) for NSCLC. Materials and methods: The records of 938 patients with inoperable NSCLC who were treated with XRT and/or EBB were reviewed. The patients were divided into five groups as follows: group XRT, treated by XRT alone (n = 421); group XRTelig, treated by XRT but eligible for EBB (n = 419); group XRTEBB, primarily treated with EBB+XRT (n = 62); group EBBrec, treated by EBB for recurrence after XRT (n = 23); and group EBB, treated by EBB alone (n = 13). EBB was delivered using HDR. Patients with bronchoscopy-proven endobronchial tumour in the proximal airways, i.e. the trachea, the main bronchus or lobar bronchus were considered eligible for EBB. Results: One hundred one out of 938 patients (10.8%) died from massive haemoptysis. The incidence was 4.3% in group XRT, 13.1% in group XRTelig and 25.4% in group XRTEBB. The differences between groups XRT and XRTelig as well as between groups XRTelig and XRTEBB were statistically significant (P < 0.01). The incidence of massive haemoptysis depended significantly on the fraction size of brachytherapy. When two fractions of 7.5 Gy or a single fraction of IO Gy were used, 11.1% of the patients died from massive haemoptysis. However, when a single dose of 15 Gy was used, 47.8% died from massive haemoptysis. In the multivariate analysis, a single dose of 15 Gy EBB was the most important prognostic factor for massive haemoptysis. Conclusion: XRT+EBB as primary treatment for NSCLC does not lead to a higher risk of massive haemoptysis as compared to XRT alone when fraction sizes for EBB of 7.5 or 10 Gy are used. However, the risk of massive haemoptysis increases dramatically when a fraction size of 15 Gy is used. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:175 / 183
页数:9
相关论文
共 26 条
[1]   TREATMENT OF NON-SMALL-CELL LUNG-CANCER WITH EXTERNAL BEAM RADIOTHERAPY AND HIGH-DOSE RATE BRACHYTHERAPY [J].
AYGUN, C ;
WEINER, S ;
SCARIATO, A ;
SPEARMAN, D ;
STARK, L .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 23 (01) :127-132
[2]  
BEDWINEK J, 1991, INT J RADIAT ONCOL, V22, P23
[3]   HIGH-DOSE-RATE AFTERLOADING INTRALUMINAL BRACHYTHERAPY IN MALIGNANT AIRWAY-OBSTRUCTION OF LUNG-CANCER [J].
CHANG, LFL ;
HORVATH, J ;
PEYTON, W ;
LING, SS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 28 (03) :589-596
[4]  
COTTER GW, 1991, SOUTHERN MED J, V84, P562
[5]   INOPERABLE ENDOBRONCHIAL OBSTRUCTING LUNG-CANCER TREATED WITH COMBINED ENDOBRONCHIAL AND EXTERNAL-BEAM IRRADIATION - A DOSIMETRIC ANALYSIS [J].
COTTER, GW ;
LARISCY, C ;
ELLINGWOOD, KE ;
HERBERT, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 (03) :531-535
[6]   HIGH-DOSE ENDOBRONCHIAL IRRADIATION IN RECURRENT BRONCHOGENIC-CARCINOMA [J].
GAUWITZ, M ;
ELLERBROEK, N ;
KOMAKI, R ;
PUTNAM, JB ;
RYAN, MB ;
DECARO, L ;
DAVIS, M ;
CUNDIFF, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 23 (02) :397-400
[7]   PHYSIOLOGICAL EFFECT OF ENDOBRONCHIAL RADIOTHERAPY IN PATIENTS WITH MAJOR AIRWAY OCCLUSION BY CARCINOMA [J].
GOLDMAN, JM ;
BULMAN, AS ;
RATHMELL, AJ ;
CAREY, BM ;
MUERS, MF ;
JOSLIN, CAF .
THORAX, 1993, 48 (02) :110-114
[8]   Massive haemoptysis death and other morbidity associated with high dose rate intraluminal radiotherapy for carcinoma of the bronchus [J].
Gollins, SW ;
Ryder, WDJ ;
Burt, PA ;
Barber, PV ;
Stout, R .
RADIOTHERAPY AND ONCOLOGY, 1996, 39 (02) :105-116
[9]   High dose rate brachytherapy for the local control of endobronchial carcinoma following external irradiation [J].
Hernandez, P ;
Gursahaney, A ;
Roman, T ;
Schwartzman, K ;
Donath, D ;
Cosio, MG ;
Levy, RD .
THORAX, 1996, 51 (04) :354-358
[10]   Does additional brachytherapy improve the effect of external irradiation? A prospective, randomized study in central lung tumors [J].
Huber, RM ;
Fischer, R ;
Hautmann, H ;
Pollinger, B ;
Haussinger, K ;
Wendt, T .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (03) :533-540